ConductScience.org, home

Paper216448

N-Aralkyl substitution increases the affinity of adrenergic drugs for the alpha-adrenoceptor in rat liver.

Aggerbeck M and 2 others. Br J Pharmacol, 1979. Cited by 14 papers, by iCite.

11 sourcespapers-2026-11-12-0.1.0

Download JSON
Cite this record

ConductScience Library. N-Aralkyl substitution increases the affinity of adrenergic drugs for the alpha-adrenoceptor in rat liver. Papers, record 216448. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/216448

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
N-Aralkyl substitution increases the affinity of adrenergic drugs for the alpha-adrenoceptor in rat liver.
PubMed
Journal
Br J Pharmacol
PubMed
Year
1979
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
14
iCite
Relative citation ratio, by iCite
0.71
iCite
Revised in PubMed
2019-05-09
PubMed

Authors3

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Aggerbeck MM
2Guellaën GG
3Hanoune JJ

Source PubMed

Topics11

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
LiverMajor topic
Receptors, AdrenergicMajor topic
Receptors, Adrenergic, alphaMajor topic
SympathomimeticsMajor topic
Alkylation
Animals
Cell Membrane
Dihydroergotoxine
Female
Rats
Structure-Activity Relationship

Source PubMed

References14

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
126,446Biochemical evidence for the dual action of labetalol on alpha- and beta-adrenoceptors.Br J Pharmacol1978https://conductscience.org/library/papers/26446PubMed
2191,710Selective labeling of alpha-noradrenergic receptors in rat brain with [3H]dihydroergokryptine.Life Sci1977https://conductscience.org/library/papers/191710PubMed
315,249Catecholamine binding to the beta-adrenergic receptor.Proc Natl Acad Sci U S A1977https://conductscience.org/library/papers/15249PubMed
421,422Potentiation of beta-sympathomimetics with alpha-adrenoceptor blocking drugs in guinea pig trachea and human bronchus preparations.Pharmacology1977https://conductscience.org/library/papers/21422PubMed
510,948A review of the animal pharmacology of labetalol, a combined alpha- and beta-adrenoceptor-blocking drug.Br J Clin Pharmacol1976https://conductscience.org/library/papers/10948PubMed
6203,582Characterization with [3H] dihydroergocryptine of the alpha-adrenergic receptor of the hepatic plasma membrane. Comparison with the beta-adrenergic receptor in normal and adrenalectomized rats.J Biol Chem1978https://conductscience.org/library/papers/203582PubMed
7195,950alpha-Adrenergic receptors in rat parotid cells. I. Correlation of [3H]dihydroergocryptine binding and catecholamine-stimulated potassium efflux.J Biol Chem1977https://conductscience.org/library/papers/195950PubMed
8825,511Identification of alpha-adrenergic receptors in uterine smooth muscle membranes by [3H]dihydroergocryptine binding.J Biol Chem1976https://conductscience.org/library/papers/825511PubMed
94,154,497Beta-adrenergic receptor: stereospecific interaction of iodinated beta-blocking agent with high affinity site.Science1974https://conductscience.org/library/papers/4154497PubMed
10180,428Transformation of the beta2 adrenoceptor in normal rat liver into a beta1 type in Zajdela hepatoma.Nature1976https://conductscience.org/library/papers/180428PubMed
114,894Alpha-adrenergic receptor identification by (3H)dihydroergocryptine binding.Science1976https://conductscience.org/library/papers/4894PubMed
124,202,581Relationship between the inhibition constant (K1) and the concentration of inhibitor which causes 50 per cent inhibition (I50) of an enzymatic reaction.Biochem Pharmacol1973https://conductscience.org/library/papers/4202581PubMed
134,967,807Isolation of an organ specific protein antigen from cell-surface membrane of rat liver.Biochim Biophys Acta1968https://conductscience.org/library/papers/4967807PubMed
145,342,360The structure-activity relationships of beta adrenergic drugs and beta adrenergic blocking drugs.Ann N Y Acad Sci1967https://conductscience.org/library/papers/5342360PubMed

Cited by3

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 14 citations.

PMIDTitleJournalYearIn PapersSource
6,298,278Adrenergic regulation of glycogenolysis in rat liver after cholestasis. Modulation of the balance between alpha 1 and beta 2 receptors.J Clin Invest1983https://conductscience.org/library/papers/6298278PubMed
6,119,625(+/-)[125Iodo] cyanopindolol, a new ligand for beta-adrenoceptors: identification and quantitation of subclasses of beta-adrenoceptors in guinea pig.Naunyn Schmiedebergs Arch Pharmacol1981https://conductscience.org/library/papers/6119625PubMed
2,908,732Properties of labetalol, a combined alpha- and beta-blocking agent, relevant to the treatment of myocardial ischemia.Cardiovasc Drugs Ther1988https://conductscience.org/library/papers/2908732PubMed

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/216448

GET https://conductscience.org/api/papers/v1/216448/authors